Lord, Abbett & Co
WGS icon

Lord, Abbett & Co’s GeneDx Holdings WGS Stock Holding History

Lord, Abbett & Co’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74M Sell
42,648
-475,656
-92% -$43.4M 0.01% 514
2025
Q4 		$67.4M Sell
518,304
-7,073
-1% -$971K 0.21% 129
2025
Q3 		$56.6M Buy
525,377
+90,905
+21% +$9.9M 0.17% 151
2025
Q2 		$40.1M Buy
434,472
+25,136
+6% +$1.97M 0.13% 187
2025
Q1 		$36.3M Sell
409,336
-221,137
-35% -$19.2M 0.13% 194
2024
Q4 		$48.5M Buy
+630,473
New +$44M 0.15% 173

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lord, Abbett & Co's WGS Position: Q1 2026 in Review

Lord, Abbett & Co reduced its GeneDx Holdings (WGS) stake by 92% in Q1 2026, selling an estimated $43.4M and leaving 42,648 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #514.

Lord, Abbett & Co first reported a position in WGS in Q4 2024 and has held it in 6 quarters since. The position peaked at $67.4M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Lord, Abbett & Co held 42,648 shares of GeneDx Holdings worth $2.74M as of Q1 2026.
  • Lord, Abbett & Co sold 475,656 GeneDx Holdings shares in Q1 2026, an estimated $43.4M.
  • GeneDx Holdings made up 0.01% of Lord, Abbett & Co's portfolio in Q1 2026, its #514 holding.
  • Lord, Abbett & Co first reported a position in GeneDx Holdings in Q4 2024 and has held it in 6 quarters since.
  • Lord, Abbett & Co's GeneDx Holdings position peaked at $67.4M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.